Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
García-Blas S, Bonanad C, Llàcer P, Ventura S, Núñez JM, Sánchez R, Chamorro C, Fácila L, de la Espriella R, Vaquer JM, Cordero A, Roqué M, Ortiz V, Racugno P, Bodí V, Valero E, Santas E, Moreno MDC, Miñana G, Carratalá A, Bondanza L, Payá A, Cardells I, Heredia R, Pellicer M, Valls G, Palau P, Bosch MJ, Raso R, Sánchez A, Bertomeu-González V, Bertomeu-Martínez V, Montagud-Balaguer V, Albiach-Montañana C, Pendás-Meneau J, Marcaida G, Cervantes-García S, San Antonio R, de Mingo E, Chorro FJ, Sanchis J, Núñez J; IMPROVE-HF Investigators. García-Blas S, et al. Among authors: chamorro c. Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1067-1073. doi: 10.1016/j.rec.2017.02.028. Epub 2017 Mar 22. Rev Esp Cardiol (Engl Ed). 2017. PMID: 28341415 Clinical Trial. English, Spanish.
CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction.
Núñez J, Llàcer P, García-Blas S, Bonanad C, Ventura S, Núñez JM, Sánchez R, Fácila L, de la Espriella R, Vaquer JM, Cordero A, Roqué M, Chamorro C, Bodi V, Valero E, Santas E, Moreno MDC, Miñana G, Carratalá A, Rodríguez E, Mollar A, Palau P, Bosch MJ, Bertomeu-González V, Lupón J, Navarro J, Chorro FJ, Górriz JL, Sanchis J, Voors AA, Bayés-Genís A. Núñez J, et al. Among authors: chamorro c. Am J Med. 2020 Mar;133(3):370-380.e4. doi: 10.1016/j.amjmed.2019.07.041. Epub 2019 Aug 15. Am J Med. 2020. PMID: 31422111 Clinical Trial.
[Impact of diabetes mellitus on heart transplant recipients].
Moro JA, Martínez-Dolz L, Almenar L, Martínez-Ortiz L, Chamorro C, García C, Arnau MA, Rueda J, Zorio E, Salvador A. Moro JA, et al. Among authors: chamorro c. Rev Esp Cardiol. 2006 Oct;59(10):1033-7. doi: 10.1157/13093980. Rev Esp Cardiol. 2006. PMID: 17125713 Free article. Spanish.
Induction therapy with daclizumab in heart transplantation--how many doses?
Ortiz V, Almenar L, Martínez-Dolz L, Zorio E, Chamorro C, Moro J, Agüero J, Rueda J, Arnau MA, Salvador A. Ortiz V, et al. Among authors: chamorro c. Transplant Proc. 2006 Oct;38(8):2541-3. doi: 10.1016/j.transproceed.2006.08.024. Transplant Proc. 2006. PMID: 17097995 Clinical Trial.
[Can heart donation exclusion factors be overcome?].
Chamorro C, Romera MA, Silva JA, Valdivia M, Ortega A. Chamorro C, et al. Rev Esp Cardiol. 2006 Mar;59(3):232-7. Rev Esp Cardiol. 2006. PMID: 16712747 Free article. Spanish.
Does amiodarone influence early mortality in heart transplantation?
Sánchez-Lázaro IJ, Almenar L, Martinez-Dolz L, Chamorro C, Moro J, Agüero J, Rueda J, Zorio E, Arnau MA, Salvador A. Sánchez-Lázaro IJ, et al. Among authors: chamorro c. Transplant Proc. 2006 Oct;38(8):2537-8. doi: 10.1016/j.transproceed.2006.08.022. Transplant Proc. 2006. PMID: 17097993 Clinical Trial.
Do cardiovascular risk factors influence cardiac allograft vasculopathy?
Chamorro CI, Almenar L, Martínez-Dolz L, Sánchez-Lacuesta E, Martín-Pastor J, Ten-Morro F, Sánchez-Soriano RM, Agüero J, Ortiz V, Moro JA, Salvador A. Chamorro CI, et al. Transplant Proc. 2006 Oct;38(8):2572-4. doi: 10.1016/j.transproceed.2006.08.034. Transplant Proc. 2006. PMID: 17098006
175 results